Kellogg W K Foundation's Form 4/A amendment
AmendedKellanovaK · filed Jul 23, 2025
- Accession no.
- 0000950170-25-097883
- Filed
- Jul 23, 2025, 4:02 PM ET
- Trade date
- Jul 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Jul 21, 2025
This filing lists 1 non-derivative transaction. Open-market sales total $9.15M. It was filed 2 days after the trade.
This amendment replaces 0000950170-25-097329 (filed Jul 21, 2025).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kellogg W K FoundationCIK 0001197916 | 10% Owner |
| Kellogg W K Foundation TrustCIK 0001197921 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Common Stock | SSaleDisposed | −114,583 | $79.87F2 | −$9,151,709.84 | 45,670,369 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
45,670,369 shares were owned following the reported transaction by the W.K. Kellogg Foundation Trust (the "Trust") of which LaJune Montgomery Tabron, Steve Cahillane, Richard M. Tsoumas and The Northern Trust Company are Trustees and the W.K. Kellogg Foundation (the "Foundation") is the sole beneficiary.
- F2
This Form 4/A is being filed to amend the original Form 4 filed on July 21, 2025, to correct an administrative error. The original filing reported an average price of $79.92 for the sale transaction that occurred on July 21, 2025. The correct average price is $79.8697.
Referenced by the price of 1 transaction in Table I.
Remarks
The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.